Thomas Gajewski serves as the Abbvie Foundation Professor of Cancer Immunotherapy and is an American Cancer Society professor at the University of Chicago. His career is marked by significant contributions to the fields of Immunology, Anti-tumor Immunity, and Cancer Immunotherapy, evidenced by over 280 peer-reviewed publications.
Dr. Gajewski's research includes defining the T cell-inflamed/non-T cell inflamed tumor microenvironment.